Cardiovascular Drugs Market – Lipid-Lowering Therapies Transforming Atherosclerosis Management
Market Overview The cardiovascular drugs market is advancing rapidly as lipid-lowering therapies evolve beyond statins to address residual cardiovascular risk in patients with familial hypercholesterolemia, statin intolerance, and established atherosclerotic disease. Proprotein convertase subtilisin kexin type 9 inhibitors, siRNA therapeutics, and oral non-statin agents now provide powerful...
0 Комментарии 0 Поделились 10 Просмотры 0 предпросмотр
BuzzingAbout https://www.buzzingabout.com